TY  - GEN
AU  - Davis,Ian D
AU  - Skrumsager,Birte K
AU  - Cebon,Jonathan
AU  - Nicholaou,Theo
AU  - Barlow,John W
AU  - Moller,Niels Peter Hundahl
AU  - Skak,Kresten
AU  - Lundsgaard,Dorthe
AU  - Frederiksen,Klaus Stensgaard
AU  - Thygesen,Peter
AU  - McArthur,Grant A
TI  - An open-label, two-arm, phase I trial of recombinant human interleukin-21 in patients with metastatic melanoma
SN  - 1078-0432
PY  - 2007///1004
KW  - Adult
KW  - Aged
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - Dose-Response Relationship, Drug
KW  - Enzyme-Linked Immunosorbent Assay
KW  - Female
KW  - Granzymes
KW  - drug effects
KW  - Humans
KW  - Interleukin-2 Receptor alpha Subunit
KW  - blood
KW  - Interleukins
KW  - Male
KW  - Maximum Tolerated Dose
KW  - Melanoma
KW  - drug therapy
KW  - Middle Aged
KW  - Perforin
KW  - Pore Forming Cytotoxic Proteins
KW  - Recombinant Proteins
KW  - Interleukin-21
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1158/1078-0432.CCR-07-0410
ER  -